ニュートリゲノミクスの世界市場:用途別(肥満、心血管疾患、がん研究)、地域別、セグメント予測

【英語タイトル】Nutrigenomics Market Size, Share & Trends Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research), By Region (North America, Latin America, Europe, MEA, APAC), And Segment Forecasts, 2019 - 2025

Grand View Researchが出版した調査資料(GVW903125)・商品コード:GVW903125
・発行会社(調査会社):Grand View Research
・発行日:2019年1月31日
・ページ数:80
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、ニュートリゲノミクスの世界市場について調査・分析し、ニュートリゲノミクスの世界市場動向、ニュートリゲノミクスの世界市場規模、市場予測、セグメント別ニュートリゲノミクス市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global nutrigenomics market size is expected to reach USD 850.86 million by 2025 registering a CAGR of 16.48%, according to a new report by Grand View Research, Inc. This growth can be attributed to the rising cases of obesity and Cardiovascular Diseases (CVDs), particularly in developed regions. Nutrigenomics can play a vital role in the prevention of obesity by offering personalized, gene-based diet. Increased awareness about the product along with growing geriatric population will also augment the market growth.
Obesity and cancer research applications of nutrigenomics emerged as the market leaders in 2017 and are expected to maintain the dominance expanding at a significant CAGR over the forecast period. Developing regional markets including Asia Pacific, Latin America, and Middle East are also expected to witness rapid expansion owing to the increased cases of obesity and growing geriatric population.

Further key findings from the study suggest:

• The global nutrigenomics demand exceeded USD 250 million in 2017 and is expected to expand at a CAGR of 16.48% over the forecast period

• Obesity application segment led the market in 2017 and is estimated to account for a 38% of the industry share by 2025

• North America accounted for the largest market share in 2017 and is estimated to maintain its dominance over the years to come

• The Asia Pacific market is projected to witness substantial growth over the next decade owing to increasing cases of obesity and CVD-related deaths

• Key participants in the global nutrigenomics market include Koninklijke DSM N.V. (Royal DSM); BASF SE; Danone; GeneSmart; Unilever; Genova Diagnostics; Inc.; Nutrigenomix, Inc.; Metagenics, Inc.; WellGen, Inc.; and Cell Logic

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Nutrigenomics Market Variables, Trends& Scope
3.1 Market segmentation& scope
3.1.1 Market Driver Analysis
3.1.1.1 Increasing prevalence of obesity
3.1.1.2 Increasing popularity for personalized diet
3.1.1.3 Intense research for cancer prevention and cure
3.1.2 Market Restrain Analysis
3.1.2.1 Lack of regulatory approvals
3.1.2.2 Lack of proven results for nutrigenomics study support
3.2 Penetration & growth prospect mapping
3.3 Nutrigenomics – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Nutrigenomics: Application Scope Estimates & Trend Analysis
4.1 Nutrigenomics market: application scope movement analysis
4.2 Obesity
4.2.1 Obesity Discovery market, 2014 – 2025 (USD Million)
4.3 Cardiovascular Diseases
4.3.1 Cardiovascular Diseases, 2014 – 2025 (USD Million)
4.4 Cancer research
4.4.1 Cancer research market, 2014 – 2025 (USD Million)
Chapter 5 Nutrigenomics: Regional Estimates & Trend Analysis, by Technique, Application, Indication Scope
5.1 Nutrigenomics market share by region, 2016 & 2025
5.2 North America
5.2.1 North America Nutrigenomics market, 2014-2025, (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. Nutrigenomics market, 2014-2025, (USD Million)
5.2.3 Canada
5.2.3.1 Canada Nutrigenomics market, 2014-2025, (USD Million)
5.3 Europe
5.3.1 Europe Nutrigenomics market, 2014-2025, (USD Million)
5.3.2 Germany
5.3.2.1 Germany Nutrigenomics market, 2014-2025, (USD Million)
5.3.3 U.K.
5.3.3.1 U.K. Nutrigenomics market, 2014-2025, (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific Nutrigenomics market, 2014-2025, (USD Million)
5.4.2 China
5.4.2.1 China Nutrigenomics market, 2014-2025, (USD Million)
5.4.3 Japan
5.4.3.1 Japan Nutrigenomics market, 2014-2025, (USD Million)
5.5 Latin America
5.5.1 Latin America Nutrigenomics market, 2014-2025, (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil Nutrigenomics market, 2014-2025, (USD Million)
5.6 Middle East and Africa
5.6.1 Middle East and Africa Nutrigenomics market, 2014-2025, (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa Nutrigenomics market, 2014-2025, (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Market participation categorization
6.2.1 Royal DSM
6.2.1.1 Company overview
6.2.1.2 Financial performance
6.2.1.3 Technique benchmarking
6.2.1.4 Strategic initiatives
6.2.2 BASF
6.2.2.1 Company overview
6.2.2.2 Financial performance
6.2.2.3 Technique benchmarking
6.2.2.4 Strategic initiatives
6.2.3 Danone
6.2.3.1 Company overview
6.2.3.2 Financial performance
6.2.3.3 Technique benchmarking
6.2.3.4 Strategic initiatives
6.2.4 GeneSmart
6.2.4.1 overview
6.2.4.2 Financial performance
6.2.4.3 Technique benchmarking
6.2.4.4 Strategic initiatives
6.2.5 Unilever
6.2.5.1 overview
6.2.5.2 Financial performance
6.2.5.3 Technique benchmarking
6.2.5.4 Strategic initiatives
6.2.6 Genova Diagnostics
6.2.6.1 Company overview
6.2.6.2 Financial performance
6.2.6.3 Technique benchmarking
6.2.6.4 Strategic initiatives
6.2.7 Nutrigenomix, Inc,
6.2.7.1 Company overview
6.2.7.2 Financial performance
6.2.7.3 Technique benchmarking
6.2.7.4 Strategic initiatives
6.2.8 Metagenics
6.2.8.1 Company overview
6.2.8.2 Financial performance
6.2.8.3 Technique benchmarking
6.2.8.4 Strategic initiatives
6.2.9 Cell Logic
6.2.9.1 Company overview
6.2.9.2 Financial performance
6.2.9.3 Technique benchmarking
6.2.9.4 Strategic initiatives
6.2.10 WellGen
6.2.10.1 Company overview
6.2.10.2 Financial performance
6.2.10.3 Technique benchmarking
6.2.10.4 Strategic initiatives

List of Tables

TABLE 1 North America Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 2 U.S. Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 3 Canada Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 4 Europe Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 5 Germany Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 6 U.K Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 7 Asia Pacific Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 8 China Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 9 Japan Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 10 Latin America Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 11 Brazil Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 12 Middle East and Africa Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)
TABLE 13 South Africa Nutrigenomics market, by application scope, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restrain relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Nutrigenomics market application scope outlook: Key takeaways
FIG. 16 Nutrigenomics market: application scope market: movement analysis
FIG. 17 Global Obesity discovery market, 2014 - 2025 (USD Million)
FIG. 18 Global Cardiovascular Diseases, 2014 - 2025 (USD Million)
FIG. 19 Global Cancer research market, 2014 - 2025 (USD Million)
FIG. 20 Regional market place: Key takeaways
FIG. 21 Regional outlook, 2017 & 2025
FIG. 22 Strategy framework
FIG. 23 Participant categorization

【掲載企業】

Royal DSM、BASF、Danone、GeneSmart、Unilever、Genova Diagnostics、Nutrigenomix, Inc,、Metagenics、Cell Logic、WellGen

★調査レポート[ニュートリゲノミクスの世界市場:用途別(肥満、心血管疾患、がん研究)、地域別、セグメント予測] (コード:GVW903125)販売に関する免責事項を必ずご確認ください。
★調査レポート[ニュートリゲノミクスの世界市場:用途別(肥満、心血管疾患、がん研究)、地域別、セグメント予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆